Here is a self-contained, interactive Clinical Dashboard for Vitiligo. It is designed to be a single HTML file that acts as a high-yield app.

You can save the code block below as an `.html` file (e.g., `vitiligo_guide.html`) and open it in any web browser.

```html
<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Vitiligo: Clinical Decision Support</title>
    <link href="https://cdnjs.cloudflare.com/ajax/libs/font-awesome/6.0.0/css/all.min.css" rel="stylesheet">
    <style>
        :root {
            --primary: #005eb8; /* NHS Blue */
            --primary-dark: #003087;
            --success: #007f3b; /* Green for Actions */
            --success-bg: #e7f5ee;
            --danger: #d4351c; /* Red for Alerts */
            --danger-bg: #fbebe8;
            --warning: #ffb81c;
            --warning-bg: #fff9e6;
            --gray-light: #f0f4f5;
            --gray-med: #d8dde0;
            --text: #212b32;
            --white: #ffffff;
            --shadow: 0 4px 6px -1px rgba(0, 0, 0, 0.1), 0 2px 4px -1px rgba(0, 0, 0, 0.06);
        }

        * { box-sizing: border-box; }
        
        body {
            font-family: 'Segoe UI', Roboto, Helvetica, Arial, sans-serif;
            background-color: var(--gray-light);
            color: var(--text);
            line-height: 1.5;
            margin: 0;
            padding: 0;
        }

        /* Header */
        header {
            background: var(--primary);
            color: var(--white);
            padding: 1rem 2rem;
            position: sticky;
            top: 0;
            z-index: 100;
            box-shadow: 0 2px 5px rgba(0,0,0,0.2);
            display: flex;
            justify-content: space-between;
            align-items: center;
        }

        header h1 { margin: 0; font-size: 1.5rem; font-weight: 600; }
        .subtitle { font-size: 0.9rem; opacity: 0.9; }

        /* Layout */
        .container {
            max-width: 1200px;
            margin: 0 auto;
            padding: 20px;
            display: grid;
            grid-template-columns: 1fr 1fr; /* Two column layout */
            gap: 20px;
        }

        @media (max-width: 768px) {
            .container { grid-template-columns: 1fr; }
        }

        /* Cards */
        .card {
            background: var(--white);
            border-radius: 8px;
            box-shadow: var(--shadow);
            padding: 20px;
            margin-bottom: 20px;
            border-top: 4px solid var(--primary);
            transition: transform 0.2s ease;
        }

        .card h2 {
            margin-top: 0;
            color: var(--primary-dark);
            font-size: 1.25rem;
            display: flex;
            align-items: center;
            gap: 10px;
            border-bottom: 1px solid var(--gray-med);
            padding-bottom: 10px;
        }

        /* Special Cards */
        .card.referral { border-top-color: var(--danger); background-color: #fffcfc; }
        .card.referral h2 { color: var(--danger); }
        
        .card.action { border-top-color: var(--success); }
        .card.action h2 { color: var(--success); }

        /* Accordions */
        .accordion {
            background-color: #fff;
            cursor: pointer;
            padding: 15px;
            width: 100%;
            text-align: left;
            border: 1px solid var(--gray-med);
            border-radius: 4px;
            margin-top: 8px;
            outline: none;
            transition: 0.4s;
            font-weight: 600;
            display: flex;
            justify-content: space-between;
            align-items: center;
        }

        .accordion:hover { background-color: #f8f9fa; }
        .accordion.active { background-color: var(--primary); color: white; border-color: var(--primary); }
        .accordion:after { content: '\002B'; font-weight: bold; float: right; margin-left: 5px; }
        .accordion.active:after { content: "\2212"; }

        .panel {
            padding: 0 15px;
            background-color: white;
            max-height: 0;
            overflow: hidden;
            transition: max-height 0.2s ease-out;
            border-left: 3px solid var(--gray-med);
            margin-bottom: 10px;
        }
        .panel p, .panel ul { margin: 15px 0; }

        /* Badges & Tags */
        .badge {
            display: inline-block;
            padding: 0.25em 0.6em;
            font-size: 0.75rem;
            font-weight: 700;
            border-radius: 1rem;
            text-transform: uppercase;
            margin-right: 5px;
        }
        .badge-red { background-color: var(--danger-bg); color: var(--danger); }
        .badge-green { background-color: var(--success-bg); color: var(--success); }
        .badge-blue { background-color: #e6f0f9; color: var(--primary); }

        /* Checklists */
        .checklist { list-style: none; padding: 0; }
        .checklist li {
            position: relative;
            padding-left: 30px;
            margin-bottom: 10px;
            cursor: pointer;
        }
        .checklist li:before {
            content: '\f0c8'; /* square */
            font-family: "Font Awesome 5 Free";
            position: absolute;
            left: 0;
            color: var(--gray-med);
        }
        .checklist li.checked:before {
            content: '\f14a'; /* check-square */
            color: var(--success);
            font-weight: 900;
        }

        /* Grid helpers */
        .full-width { grid-column: 1 / -1; }

        /* Dosage Box */
        .dosage-box {
            background-color: var(--gray-light);
            border-left: 4px solid var(--primary);
            padding: 10px;
            font-family: monospace;
            margin-top: 10px;
        }

        /* Tooltip/Hover hint */
        .tooltip {
            border-bottom: 1px dotted var(--text);
            cursor: help;
        }

    </style>
</head>
<body>

<header>
    <div>
        <h1>Vitiligo CKS Guide</h1>
        <span class="subtitle">Revised April 2025 | Rapid Primary Care Dashboard</span>
    </div>
    <div>
        <i class="fas fa-user-md fa-2x"></i>
    </div>
</header>

<div class="container">

    <!-- 1. IMMEDIATE REFERRAL CRITERIA (Red Flags) -->
    <article class="card referral full-width">
        <h2><i class="fas fa-exclamation-circle"></i> Referral Criteria</h2>
        <div style="display: grid; grid-template-columns: repeat(auto-fit, minmax(250px, 1fr)); gap: 15px;">
            <div class="alert-item">
                <span class="badge badge-red">Urgent/Routine</span>
                <strong>Diagnosis Uncertain</strong>
                <p class="small">Features atypical (inflammation, scaling, scarring).</p>
            </div>
            <div class="alert-item">
                <span class="badge badge-red">Urgent</span>
                <strong>Rapid Progression</strong>
                <p class="small">Spreading quickly or active disease.</p>
            </div>
            <div class="alert-item">
                <span class="badge badge-red">Routine</span>
                <strong>Segmental Vitiligo</strong>
                <p class="small">Unilateral/dermatomal distribution (stabilizes quickly, harder to treat).</p>
            </div>
            <div class="alert-item">
                <span class="badge badge-red">Routine</span>
                <strong>High Impact</strong>
                <p class="small">>10% Body Surface Area OR Significant psychosocial distress.</p>
            </div>
            <div class="alert-item">
                <span class="badge badge-red">Routine</span>
                <strong>Treatment Failure</strong>
                <p class="small">No response to topical treatments or contraindications exist.</p>
            </div>
        </div>
    </article>

    <!-- 2. DIAGNOSIS & ASSESSMENT -->
    <section class="column-left">
        <article class="card">
            <h2><i class="fas fa-search"></i> Diagnosis & Assessment</h2>
            
            <p><strong>Presentation:</strong> Well-demarcated, chalky white macules. Non-scaly. Often symmetrical (non-segmental).</p>
            
            <button class="accordion">Key Assessment Questions</button>
            <div class="panel">
                <ul>
                    <li><strong>Onset:</strong> Age? Speed? Trigger (stress, trauma)?</li>
                    <li><strong>Symptoms:</strong> Usually asymptomatic, itch may precede lesions.</li>
                    <li><strong>History:</strong> Family hx of vitiligo or Autoimmune (Thyroid, Addison's, B12, Diabetes).</li>
                    <li><strong>Skin Type:</strong> Fitzpatrick classification (affects treatment options).</li>
                </ul>
            </div>

            <button class="accordion">Signs of Active Disease</button>
            <div class="panel">
                <ul>
                    <li><strong>Koebner Phenomenon:</strong> Depigmentation at trauma sites.</li>
                    <li><strong>Trichrome:</strong> Three shades of color.</li>
                    <li><strong>Inflamed borders:</strong> Redness at edges.</li>
                    <li><strong>Confetti-like:</strong> Small scattered macules.</li>
                </ul>
            </div>

            <button class="accordion">Differential Diagnosis (Rule Out)</button>
            <div class="panel">
                <ul>
                    <li><strong>Pityriasis Versicolor:</strong> <span class="badge badge-blue">Scale</span> Fine scale, upper trunk.</li>
                    <li><strong>Pityriasis Alba:</strong> <span class="badge badge-blue">Children</span> Ill-defined, subtle scale, face/arms.</li>
                    <li><strong>Post-inflammatory:</strong> History of eczema/psoriasis.</li>
                    <li><strong>Halo Naevus:</strong> Mole with white ring.</li>
                    <li><strong>Chemical Depigmentation:</strong> Occ hx (phenols, dyes).</li>
                </ul>
            </div>

            <div style="margin-top: 15px; background: var(--warning-bg); padding: 10px; border-radius: 4px;">
                <strong><i class="fas fa-vial"></i> Investigations:</strong>
                <br>Check <strong>Thyroid Function & Antibodies</strong> (TPO) for all patients. Consider B12/Folate or Glucose if indicated.
            </div>
        </article>

        <article class="card">
            <h2><i class="fas fa-users"></i> Psychosocial Support</h2>
            <p>Assess impact on QoL (DLQI, PHQ-9). Vitiligo carries high risk of anxiety/depression.</p>
            <ul>
                <li><strong>Mild distress:</strong> Self-help resources (see below).</li>
                <li><strong>Mod/Severe distress:</strong> Refer for psychological services (CBT).</li>
            </ul>
            <hr>
            <strong>Resources:</strong>
            <ul>
                <li><a href="https://vitiligosociety.org" target="_blank">The Vitiligo Society</a></li>
                <li><a href="https://www.changingfaces.org.uk" target="_blank">Changing Faces</a> (Camouflage advice)</li>
            </ul>
        </article>
    </section>

    <!-- 3. MANAGEMENT -->
    <section class="column-right">
        <article class="card action">
            <h2><i class="fas fa-clipboard-check"></i> Management Steps</h2>
            
            <div class="step">
                <h3>1. General Advice (For All)</h3>
                <ul class="checklist">
                    <li><strong>Sun Protection:</strong> SPF 50+, 5-star UVA. (Prescribe: <em>Uvistat®</em> ACBS).</li>
                    <li><strong>Avoid Trauma:</strong> Reduce friction (clothing) to prevent Koebnerization.</li>
                    <li><strong>Camouflage:</strong> Offer referral to skin camouflage service. (Prescribe: <em>Dermacolor®, Covermark®</em> ACBS).</li>
                </ul>
            </div>

            <div class="step">
                <h3>2. Topical Corticosteroids (TCS)</h3>
                <span class="badge badge-green">First Line</span> <span class="badge badge-blue">Off-label</span>
                <p>For adults with non-segmental vitiligo (Body/Limbs).</p>
                <div class="dosage-box">
                    <strong>Rx:</strong> Potent (e.g., Betamethasone 0.1%) or Very Potent (e.g., Clobetasol)<br>
                    <strong>Dose:</strong> Apply OD (Once Daily).<br>
                    <strong>Review:</strong> Every 3-6 months. Monitor for atrophy/striae.
                </div>
                <p class="small text-muted"><em>Note: Avoid potent TCS on face/neck long-term.</em></p>
            </div>

            <div class="step">
                <h3>3. Topical Calcineurin Inhibitors (TCI)</h3>
                <span class="badge badge-warning">Consider</span> <span class="badge badge-blue">Face/Flexures</span>
                <p>Alternative to TCS for <strong>Face/Neck</strong> or children. *</p>
                <div class="dosage-box">
                    <strong>Rx:</strong> Tacrolimus 0.03%/0.1% or Pimecrolimus<br>
                    <strong>Dose:</strong> Apply BD (Twice Daily).<br>
                    <strong>Safety:</strong> Avoid in pregnancy. Sun protection crucial.
                </div>
                <p class="small" style="color: var(--danger);">* <em>Caveat:</em> CKS states "if expertise available" or seek specialist advice. Check local formulary.</p>
            </div>
        </article>

        <article class="card">
            <h2><i class="fas fa-info-circle"></i> Prognosis & Skin Types</h2>
            <button class="accordion">Fitzpatrick Skin Types</button>
            <div class="panel">
                <table style="width:100%; font-size: 0.9rem; border-collapse: collapse;">
                    <tr><th style="text-align:left">Type</th><th>Features</th></tr>
                    <tr><td>I-II</td><td>Pale/Fair. Burns easily. No/Poor tan.</td></tr>
                    <tr><td>III-IV</td><td>White to Light Brown. Tans.</td></tr>
                    <tr><td>V-VI</td><td>Brown to Black. Rarely burns.</td></tr>
                </table>
                <p class="small"><em>Note: Vitiligo is more visually prominent in Types IV-VI, potentially causing higher psychosocial impact.</em></p>
            </div>

            <button class="accordion">Course of Disease</button>
            <div class="panel">
                <ul>
                    <li><strong>Non-segmental:</strong> Unpredictable. Flares and stability. Spontaneous repigmentation uncommon.</li>
                    <li><strong>Segmental:</strong> Rapid onset, stabilizes quickly. Persistent.</li>
                    <li><strong>Best response:</strong> Face, neck, trunk.</li>
                    <li><strong>Poor response:</strong> Hands, feet, lips.</li>
                </ul>
            </div>
        </article>
    </section>

</div>

<script>
    // Accordion Functionality
    var acc = document.getElementsByClassName("accordion");
    var i;

    for (i = 0; i < acc.length; i++) {
        acc[i].addEventListener("click", function() {
            this.classList.toggle("active");
            var panel = this.nextElementSibling;
            if (panel.style.maxHeight) {
                panel.style.maxHeight = null;
            } else {
                panel.style.maxHeight = panel.scrollHeight + "px";
            }
        });
    }

    // Simple Checklist Toggle
    var checklistItems = document.querySelectorAll('.checklist li');
    checklistItems.forEach(function(item) {
        item.addEventListener('click', function() {
            this.classList.toggle('checked');
        });
    });
</script>

</body>
</html>
